...
search icon
iva-img

Inventiva Sa Share Price

IVA
NMQ
$6.17
-$0.03
(-0.48%)
1D
Industry: Biotechnology Sector: Health Care

Inventiva Sa Analyst Forecast

Inventiva Sa Share Price Chart

Inventiva Sa Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.28B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
476.58K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.78
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.46 L
$7.98 H
$6.17

About Inventiva Sa, Common Stock

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France. more

Industry: BiotechnologySector: Health Care

Inventiva Sa Stock Returns

Time FrameIVASectorS&P500
1-Week Return4.93%-1.08%-1.38%
1-Month Return8.06%-0.47%-1.81%
3-Month Return61.52%2.13%1.38%
6-Month Return53.48%17.04%5.68%
1-Year Return148.79%6.56%11.74%
3-Year Return1.82%16.78%65.15%
5-Year Return-63.05%34.34%73.68%
10-Year Return-54.02%137.88%260.03%

Inventiva Sa Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue372.00K4.19M12.18M17.48M9.20M[{"date":"2020-12-31","value":2.13,"profit":true},{"date":"2021-12-31","value":24,"profit":true},{"date":"2022-12-31","value":69.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":52.63,"profit":true}]
Cost of Revenue846.00K1.02M995.00K(23.00K)-[{"date":"2020-12-31","value":83.19,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.84,"profit":true},{"date":"2023-12-31","value":-2.26,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit372.00K4.19M12.18M17.50M9.20M[{"date":"2020-12-31","value":2.13,"profit":true},{"date":"2021-12-31","value":23.97,"profit":true},{"date":"2022-12-31","value":69.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":52.56,"profit":true}]
Gross Margin100.00%100.00%100.00%100.13%100.00%[{"date":"2020-12-31","value":99.87,"profit":true},{"date":"2021-12-31","value":99.87,"profit":true},{"date":"2022-12-31","value":99.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":99.87,"profit":true}]
Operating Expenses30.09M56.31M69.29M120.19M106.76M[{"date":"2020-12-31","value":25.04,"profit":true},{"date":"2021-12-31","value":46.85,"profit":true},{"date":"2022-12-31","value":57.65,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":88.83,"profit":true}]
Operating Income(29.72M)(52.11M)(57.11M)(102.71M)(97.56M)[{"date":"2020-12-31","value":-2971800000,"profit":false},{"date":"2021-12-31","value":-5211400000,"profit":false},{"date":"2022-12-31","value":-5711000000,"profit":false},{"date":"2023-12-31","value":-10270900000,"profit":false},{"date":"2024-12-31","value":-9755800000,"profit":false}]
Total Non-Operating Income/Expense(7.80M)2.76M5.63M(11.34M)(97.41M)[{"date":"2020-12-31","value":-138.57,"profit":false},{"date":"2021-12-31","value":48.95,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-201.4,"profit":false},{"date":"2024-12-31","value":-1729.62,"profit":false}]
Pre-Tax Income(33.62M)(49.27M)(54.29M)(109.82M)(183.90M)[{"date":"2020-12-31","value":-3362000000,"profit":false},{"date":"2021-12-31","value":-4927200000,"profit":false},{"date":"2022-12-31","value":-5429400000,"profit":false},{"date":"2023-12-31","value":-10981900000,"profit":false},{"date":"2024-12-31","value":-18390100000,"profit":false}]
Income Taxes(2.00M)364.00K(20.00K)607.00K313.00K[{"date":"2020-12-31","value":-329,"profit":false},{"date":"2021-12-31","value":59.97,"profit":true},{"date":"2022-12-31","value":-3.29,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":51.57,"profit":true}]
Income After Taxes(31.62M)(49.64M)(54.27M)(110.43M)(184.21M)[{"date":"2020-12-31","value":-3162300000,"profit":false},{"date":"2021-12-31","value":-4963600000,"profit":false},{"date":"2022-12-31","value":-5427400000,"profit":false},{"date":"2023-12-31","value":-11042600000,"profit":false},{"date":"2024-12-31","value":-18421400000,"profit":false}]
Income From Continuous Operations(33.62M)(49.64M)(54.27M)(110.42M)(184.21M)[{"date":"2020-12-31","value":-3362000000,"profit":false},{"date":"2021-12-31","value":-4963900000,"profit":false},{"date":"2022-12-31","value":-5427400000,"profit":false},{"date":"2023-12-31","value":-11042500000,"profit":false},{"date":"2024-12-31","value":-18421400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(31.62M)(49.64M)(54.27M)(110.43M)(184.21M)[{"date":"2020-12-31","value":-3162300000,"profit":false},{"date":"2021-12-31","value":-4963600000,"profit":false},{"date":"2022-12-31","value":-5427400000,"profit":false},{"date":"2023-12-31","value":-11042600000,"profit":false},{"date":"2024-12-31","value":-18421200000,"profit":false}]
EPS (Diluted)(1.50)(1.71)(0.28)(3.30)(3.93)[{"date":"2020-12-31","value":-149.55,"profit":false},{"date":"2021-12-31","value":-170.84,"profit":false},{"date":"2022-12-31","value":-27.58,"profit":false},{"date":"2023-12-31","value":-330.12,"profit":false},{"date":"2024-12-31","value":-393.16,"profit":false}]

Inventiva Sa Ratios

Inventiva Sa Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

IVA
Cash Ratio 2.09
Current Ratio 2.95

Inventiva Sa Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IVA
ROA (LTM) -56.77%
ROE (LTM) -1642.76%

Inventiva Sa Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IVA
Debt Ratio Lower is generally better. Negative is bad. 1.05
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.05

Inventiva Sa Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IVA
Trailing PE NM
Forward PE NM
P/S (TTM) 75.90
P/B 2.10
Price/FCF NM
EV/R 71.20
EV/Ebitda NM

FAQs

What is Inventiva Sa share price today?

Inventiva Sa (IVA) share price today is $6.17

Can Indians buy Inventiva Sa shares?

Yes, Indians can buy shares of Inventiva Sa (IVA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IVA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Inventiva Sa be purchased?

Yes, you can purchase fractional shares of Inventiva Sa (IVA) via the Vested app. You can start investing in Inventiva Sa (IVA) with a minimum investment of $1.

How to invest in Inventiva Sa shares from India?

You can invest in shares of Inventiva Sa (IVA) via Vested in three simple steps:

  • Click on Sign Up or Invest in IVA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Inventiva Sa shares
What is Inventiva Sa 52-week high and low stock price?

The 52-week high price of Inventiva Sa (IVA) is $7.98. The 52-week low price of Inventiva Sa (IVA) is $2.46.

What is Inventiva Sa price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Inventiva Sa (IVA) is

What is Inventiva Sa price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Inventiva Sa (IVA) is 2.10

What is Inventiva Sa dividend yield?

The dividend yield of Inventiva Sa (IVA) is 0.00%

What is the Market Cap of Inventiva Sa?

The market capitalization of Inventiva Sa (IVA) is $1.28B

What is Inventiva Sa's stock symbol?

The stock symbol (or ticker) of Inventiva Sa is IVA

How Can Investors Use Inventiva Sa Share Price Data for Long-Term Investment Decisions?

Consider the share price of Inventiva Sa as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Inventiva Sa has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Inventiva Sa shares for Indian investors?

When investing in Inventiva Sa shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Inventiva Sa stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Inventiva Sa share price with other stocks in the same sector?

Rather than merely checking the share price of Inventiva Sa and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Inventiva Sa stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top